Metastatic Non-Small Cell Lung Cancer Insomnia

Overview

About this study

The purpose of this study is to evaluate the frequency of insomnia in patients with metastatic non-small cell lung cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Have a diagnosis of metastatic non small cell lung cancer.
Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy.
Subjects will be limited to older than 18 years old at the time of diagnosis.

Exclusion Criteria:

Have advanced terminal cancer, severe depression, or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing).
Regular use of psychotropic medication other than hypnotics (e.g., antidepressants) per chart review.

Eligibility last updated 9/2/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Konstantinos Leventakos, M.D., Ph.D.	Open for enrollment	Contact information: Ailsa Luce P.A.-C. (507) 293-0504 Luce.Ailsa@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Leventakos, M.D., Ph.D.

Open for enrollment

Contact information:

Ailsa Luce P.A.-C.

(507) 293-0504

Luce.Ailsa@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials